1kit (10Vial) .
| Di tin dɛn we yu kin gɛt: | |
|---|---|
| Kwantiti: . | |
▎ Wetin na BPC-157?
BPC-157 (Bכdi Protεkshכn Kכmpawnd-157) na nכchכral bayoaktiv pεptida we dεn aylכt εn purify frכm hכman gastric mכkus protin εkstrakt. i kכmכp fכ 15 amino asid dεm, i de kכnstכt wan aktv fragmεnt fכ εndojεnik gεstroprotεktiv pεpti dεm. in stebul strכkchכ de sho rεsistεns to gastric asid εn εnzym dεgradashכn. i de mεnten bayoaktiviti nכto כnli tru injεkshכn bכt i de mεnten am bay mכt, i nכ nid nכ kכmpleks fכmyuleshכn modifyushכn fכ εksyεrt in ifekt dεm. naw na wan pan di pεptida mכlikul dεm we dεn stכdi bכku fכ ripa εn protεkshכn di tisu.
BPC-157 de protεkt di tisu rigεnεreshכn εn ripa bay we i de aktibכt di fibroblast proliferashכn, aksεlεrayt kolagen sεntesis, εn indyuz angiojεnεsis fכ rεstכr di kכnektiv tisu dεm we dεn dכn lεk mכsul dεm, tεndon dεm, ligament dεm, εn skin. i de mכdulet di εkstrasεlula matris mεtabolism bak fכ ridyus di fכmeshכn fכ ska tisu. i de sho anti-inflammatory εn immunomodulatory ifekt dεm bay we i de sכpres pro-inflammatory fכktכ rilis (εgz., TNF-α, IL-6), i de ridyus inflammatory rεspכns intensiti, εn i de εliviet tisu εdima εn pen. i de gi di vishכral protεkshכn, patikyular i de gi pכtεnt difεns fכ di dijestiv mכkus (bεlε, intestin) bay we i de εnhans di mכkus barεri integriti εn ridyus di damej frכm gεstrik asid כ mεdikeshכn. i de protεkt כgan dεm lεk di liva εn kidni dεm bak, i de mitigate di כksidεtiv strεs εn di damej we tכxin de mek.
Dɛn kin yuz am as adjɔnt tɛrapi fɔ spɔt injuri lɛk tɛndinayt, mɔsul strɛs, ɛn ligamɛnt te, we kin mek di tɛm fɔ wɛl shɔt ɛn ridyus di tɛm we atletik nɔ kin wok fayn. insay di gεstrointestinal sik mεnejmεnt, i de adrεs kכndishכn dεm lεk gastric כlsa, duodenal כlsa, εn inflammatory bowel disease (εgz., Crohn’s disease) bay we i de protεkt di mכkus, protεkt di mכkus rεpa, εn i de mek di bכdi pen εn di כlsa de hεl sloslo. insay כgan protεkshכn εn ripa risεch, i de wok lεk adjunktiv intavεnshכn fכ mitigate di dכg-indyus liva injuri εn kεmikכl nεfrotoksisiti, we i de sho bak fכ ripa di nεv dεm we dεn dכn pwεl (εgz., pεrifεral nεv kכntushכn).
▎ Wetin na TB4?
TB4 (Thymosin Beta-4) na εndojεnik pεptida we kכmכp fכ 43 amino asid dεm, we kכmכt frכm di kכr aktv rijyכn fכ nכchכral hכman taymosin β4. i de sho fayn fayn wata sכlubiliti εn strכkchכral stεbiliti, nכmal wan i de apin bכku bכku wan insay tisu dεm lεk bכdi, mכsul, εn skin, εn dεn kin gεt am tru sεntetik mεtכd dεm. we yu kכmpεr wit intakt taymosin β4, TB4 de rεtεn di ki bayolojikal aktiviti we i de absכp mכr rεdi fכ di tisu dεm via injεkshכn. i de wok we i nכ nid kכmpleks modifyushכn dεm, we de mek i bi wan pan di pεptida mכlikul dεm we dεn stכdi bכku pan di fild fכ ripa tisu.
TB4 de promuot sel maygrεshכn εn tisu rigεnεreshכn bay we i de aktibכt di maygrεshכn kapasiti fכ ripa-rεlatεd sεl dεm lεk εndoteyl sεl dεm εn fibroblast dεm. i de aksεlεrayt di angiojεnεsis εn kolagen dεposishכn, we de εp fכ ripa di kכnektiv tisu injuri dεm na di mכsul dεm, tεndon dεm, ligament dεm, εn skin. di sem tεm, i de rεgεl εkstra sεlyul matris bεlε fכ ridyus di fכmeshכn we pasmak ska. i de sho anti-inflammatory εn cytoprotective ifekt dεm bay we i de inhibit di rilis fכ pro-inflammatory fכktכ dεm lεk TNF-α εn IL-1β, we de ridyus di tisu inflameshn εn εdima. pan tap dat, i de εnhans di sεl antioksidant strεs rεsistεns, mitigate di damej frכm ischemia εn tכxin dεm, εn i de ple imכtant rol fכ stεbyul di maykro envayroment fכ di tisu dεm we injuri.
Dɛn kin yuz am as adjɔnt tɛrapi fɔ injuri dɛn we gɛt fɔ du wit spɔt lɛk we di mɔsul dɛn kin strɛs, tɛndinayt, ɛn di ligamɛnt we kin te, we kin mek di saykl we pɔsin kin wɛl shɔt ɛn ɛp fɔ mek di atletik wok bak. insay wund dεm we de hεl, i de aksεlεrayt di kכlos fכ di krεse we nכ de hεl (εgz., dayabεtik fut כlsa) εn bכn injuri dεm bay we i de protεkt granulεshכn tisu gro εn di εpitεlial sεl mכvεshכn. insay tisu dεmεj intavεnshכn, i de sho bak efεktiv in nεv injuri (εgz., pεrifεral nεv kכntyushכn) εn post-mayokardial ischemia ripa stכdi dεm.
Dɔn
di BPC-157/TB4 Blεnd na kכmכpכsit sistεm we kכmכp tu εndojεnik pεpti dεm wit tisu ripa aktiviti. BPC-157, we kכmכt frכm hכman gεstrik mכkus protin, gεt 15 amino asid dεm, we TB4 na aktv fragmεnt fכ taymosin β4, we kכmכp 43 amino asid dεm. We dɛn jɔyn dɛn togɛda, dɛn kin gɛt sinajɛstik ifɛkt. BPC-157 de promuot fibroblast proliferashכn, εnhans mכkus barεri integriti, εn sכpres pro-inflammatory fכktכ rilis, we TB4 de rεgεl aktin polimεrayzeshn, aksεlεrayt sεl maygrεshכn, εn stimulat angiojεnεsis. tכgeda, dεn de εnhans di tisu rigεnεreshכn εn ripa efyushכn, wit adishכnal anti-inflammatory ifekt dεm, vishכral כgan protεkshכn, εn impruvmεnt fכ di sεlyul maykro envayroment. di risach we dεn de du naw fכ di aplikεshכn de fכkus pan sכpכt injuri rεkכvεshכn (εgz., tεndinayt, mכsul strεn, ligament injuri); di gεstrointestinal mכkus protεkshכn (εgz., gastric כlsa, inflammatory bכwel sik adjunktiv intavεnshכn); εn mכlti-tisu dεmεj sinagεstik rεstכreshכn (εgz., skin wund dεm, sכm sכm vishכnal injuri dεm). dis komplimentari mεkanism de sכt di ripa saykl dεm, i de ridyus di inflammatory rεspכns dεm, εn i de mek i izi fכ intavεnshכn insay di tisu dεm we de rilet to di tisu dεm.
Bɔt di pɔsin we rayt di buk
Di tin dɛn we wi dɔn tɔk bɔt, na ɔl di tin dɛn we Cocer Peptides dɔn du risach, ɛdit ɛn kɔmpilayt.
ƆL DI ATIKUL ƐN PRODƆKT INFƆMƐSHƆN WE DƐN GI NA DIS WƐBSAYT NA FƆ ƆL FƆ DI INFƆMƐSHƆN ƐN FƆ EDYUKESHƆN.
Di prɔdak dɛn we dɛn gi na dis wɛbsayt na fɔ in vitro risach nɔmɔ. in vitro risach (Latin: *in glas*, we min insay glas) dεn de du am ausayd mכtalman bכdi. Dɛn prɔdak ya nɔto famasitik, dɛn nɔ gɛt di aprɔval frɔm di US Food and Drug Administration (FDA), ɛn dɛn nɔ fɔ yuz dɛn fɔ protɛkt, trit, ɔ mɛn ɛni mɛrɛsin, sik, ɔ sik. Di lɔ nɔ gri fɔ mek dɛn put dɛn tin ya insay mɔtalman ɔ animal bɔdi ɛni we.